These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The "Janus face" of the thrombin binding aptamer: Investigating the anticoagulant and antiproliferative properties through straightforward chemical modifications. Esposito V; Russo A; Amato T; Vellecco V; Bucci M; Mayol L; Russo G; Virgilio A; Galeone A Bioorg Chem; 2018 Feb; 76():202-209. PubMed ID: 29190476 [TBL] [Abstract][Full Text] [Related]
3. Thrombin binding aptamer analogues containing inversion of polarity sites endowed with antiproliferative and anti-motility properties against Calu-6 cells. Esposito V; Russo A; Vellecco V; Bucci M; Russo G; Mayol L; Virgilio A; Galeone A Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2645-2650. PubMed ID: 30071274 [TBL] [Abstract][Full Text] [Related]
4. Backbone modified TBA analogues endowed with antiproliferative activity. Esposito V; Russo A; Amato T; Varra M; Vellecco V; Bucci M; Russo G; Virgilio A; Galeone A Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1213-1221. PubMed ID: 27663232 [TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxymethyl-2'-deoxyuridine residues in the thrombin binding aptamer: investigating anticoagulant activity by making a tiny chemical modification. Virgilio A; Petraccone L; Scuotto M; Vellecco V; Bucci M; Mayol L; Varra M; Esposito V; Galeone A Chembiochem; 2014 Nov; 15(16):2427-34. PubMed ID: 25214456 [TBL] [Abstract][Full Text] [Related]
6. Site-specific replacement of the thymine methyl group by fluorine in thrombin binding aptamer significantly improves structural stability and anticoagulant activity. Virgilio A; Petraccone L; Vellecco V; Bucci M; Varra M; Irace C; Santamaria R; Pepe A; Mayol L; Esposito V; Galeone A Nucleic Acids Res; 2015 Dec; 43(22):10602-11. PubMed ID: 26582916 [TBL] [Abstract][Full Text] [Related]
7. Improving the Biological Properties of Thrombin-Binding Aptamer by Incorporation of 8-Bromo-2'-Deoxyguanosine and 2'-Substituted RNA Analogues. Virgilio A; Benigno D; Aliberti C; Vellecco V; Bucci M; Esposito V; Galeone A Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958511 [TBL] [Abstract][Full Text] [Related]
8. Cation Coordination Alters the Conformation of a Thrombin-Binding G-Quadruplex DNA Aptamer That Affects Inhibition of Thrombin. Zavyalova E; Tagiltsev G; Reshetnikov R; Arutyunyan A; Kopylov A Nucleic Acid Ther; 2016 Oct; 26(5):299-308. PubMed ID: 27159247 [TBL] [Abstract][Full Text] [Related]
9. Thrombin binding aptamer, more than a simple aptamer: chemically modified derivatives and biomedical applications. Avino A; Fabrega C; Tintore M; Eritja R Curr Pharm Des; 2012; 18(14):2036-47. PubMed ID: 22376107 [TBL] [Abstract][Full Text] [Related]
11. Expanding the potential of G-quadruplex structures: formation of a heterochiral TBA analogue. Virgilio A; Varra M; Scuotto M; Capuozzo A; Irace C; Mayol L; Esposito V; Galeone A Chembiochem; 2014 Mar; 15(5):652-5. PubMed ID: 24520055 [TBL] [Abstract][Full Text] [Related]
12. Site specific replacements of a single loop nucleoside with a dibenzyl linker may switch the activity of TBA from anticoagulant to antiproliferative. Scuotto M; Rivieccio E; Varone A; Corda D; Bucci M; Vellecco V; Cirino G; Virgilio A; Esposito V; Galeone A; Borbone N; Varra M; Mayol L Nucleic Acids Res; 2015 Sep; 43(16):7702-16. PubMed ID: 26250112 [TBL] [Abstract][Full Text] [Related]
13. Exploring New Potential Anticancer Activities of the G-Quadruplexes Formed by [(GTG Virgilio A; Benigno D; Pecoraro A; Russo A; Russo G; Esposito V; Galeone A Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208896 [TBL] [Abstract][Full Text] [Related]
14. Improving Thermodynamic Stability and Anticoagulant Activity of a Thrombin Binding Aptamer by Incorporation of 8-trifluoromethyl-2'-deoxyguanosine. Bao HL; Ishizuka T; Yamashita A; Furukoji E; Asada Y; Xu Y J Med Chem; 2021 Jan; 64(1):711-718. PubMed ID: 33289557 [TBL] [Abstract][Full Text] [Related]
15. Properties and Potential Antiproliferative Activity of Thrombin-Binding Aptamer (TBA) Derivatives with One or Two Additional G-Tetrads. Benigno D; Virgilio A; Bello I; La Manna S; Vellecco V; Bucci M; Marasco D; Panza E; Esposito V; Galeone A Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499249 [TBL] [Abstract][Full Text] [Related]
16. Investigating the properties of TBA variants with twin thrombin binding domains. Amato T; Virgilio A; Pirone L; Vellecco V; Bucci M; Pedone E; Esposito V; Galeone A Sci Rep; 2019 Jun; 9(1):9184. PubMed ID: 31235717 [TBL] [Abstract][Full Text] [Related]
17. Stability and bioactivity of thrombin binding aptamers modified with D-/L-isothymidine in the loop regions. Cai B; Yang X; Sun L; Fan X; Li L; Jin H; Wu Y; Guan Z; Zhang L; Zhang L; Yang Z Org Biomol Chem; 2014 Nov; 12(44):8866-76. PubMed ID: 25264858 [TBL] [Abstract][Full Text] [Related]
18. Dissecting the contribution of thrombin exosite I in the recognition of thrombin binding aptamer. Pica A; Russo Krauss I; Merlino A; Nagatoishi S; Sugimoto N; Sica F FEBS J; 2013 Dec; 280(24):6581-8. PubMed ID: 24128303 [TBL] [Abstract][Full Text] [Related]
19. Structural and Binding Effects of Chemical Modifications on Thrombin Binding Aptamer (TBA). Valsangkar V; Vangaveti S; Lee GW; Fahssi WM; Awan WS; Huang Y; Chen AA; Sheng J Molecules; 2021 Jul; 26(15):. PubMed ID: 34361773 [TBL] [Abstract][Full Text] [Related]
20. Improving Structural Stability and Anticoagulant Activity of a Thrombin Binding Aptamer by Aromatic Modifications. Busschaert N; Maity D; Samanta PK; English NJ; Hamilton AD Chembiochem; 2022 Mar; 23(6):e202100670. PubMed ID: 34985829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]